Vanguard Group’s General Moly, Inc. GMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,352,989
Closed -$263K 4265
2020
Q3
$263K Sell
2,352,989
-71,757
-3% -$13.3K ﹤0.01% 3922
2020
Q2
$487K Hold
2,424,746
﹤0.01% 3773
2020
Q1
$388K Hold
2,424,746
﹤0.01% 3728
2019
Q4
$551K Hold
2,424,746
﹤0.01% 3777
2019
Q3
$630K Buy
2,424,746
+239,390
+11% +$59.8K ﹤0.01% 3765
2019
Q2
$765K Sell
2,185,356
-28,988
-1% -$8.32K ﹤0.01% 3745
2019
Q1
$481K Buy
2,214,344
+44,634
+2% +$11K ﹤0.01% 3780
2018
Q4
$488K Sell
2,169,710
-1,151,125
-35% -$262K ﹤0.01% 3738
2018
Q3
$1.23M Sell
3,320,835
-28,385
-0.8% -$11.1K ﹤0.01% 3673
2018
Q2
$1.37M Sell
3,349,220
-115
-0% -$45 ﹤0.01% 3604
2018
Q1
$1.27M Buy
3,349,335
+1,221,541
+57% +$478K ﹤0.01% 3595
2017
Q4
$701K Sell
2,127,794
-31,873
-1% -$10.1K ﹤0.01% 3683
2017
Q3
$810K Buy
2,159,667
+2,248
+0.1% +$950 ﹤0.01% 3643
2017
Q2
$797K Sell
2,157,419
-40,070
-2% -$13.7K ﹤0.01% 3621
2017
Q1
$1.1M Sell
2,197,489
-130,908
-6% -$62.9K ﹤0.01% 3555
2016
Q4
$582K Sell
2,328,397
-52,821
-2% -$13.7K ﹤0.01% 3705
2016
Q3
$667K Sell
2,381,218
-15,697
-0.7% -$4.99K ﹤0.01% 3684
2016
Q2
$827K Hold
2,396,915
﹤0.01% 3659
2016
Q1
$814K Sell
2,396,915
-300
-0% -$71 ﹤0.01% 3654
2015
Q4
$480K Buy
2,397,215
+54,905
+2% +$15K ﹤0.01% 3844
2015
Q3
$676K Buy
2,342,310
+9,210
+0.4% +$4.49K ﹤0.01% 3756
2015
Q2
$1.65M Buy
2,333,100
+9,420
+0.4% +$6.7K ﹤0.01% 3489
2015
Q1
$1.19M Buy
2,323,680
+41,980
+2% +$21.4K ﹤0.01% 3587
2014
Q4
$1.3M Buy
2,281,700
+9,772
+0.4% +$5.5K ﹤0.01% 3436
2014
Q3
$1.69M Buy
2,271,928
+63,334
+3% +$62K ﹤0.01% 3332
2014
Q2
$2.54M Buy
2,208,594
+6,789
+0.3% +$7.08K ﹤0.01% 3157
2014
Q1
$2.18M Buy
2,201,805
+124,114
+6% +$151K ﹤0.01% 3184
2013
Q4
$2.78M Sell
2,077,691
-144,074
-6% -$207K ﹤0.01% 3058
2013
Q3
$3.67M Buy
2,221,765
+19,089
+0.9% +$34.4K ﹤0.01% 2896
2013
Q2
$4.12M Buy
+2,202,676
New +$4.34M ﹤0.01% 2770

Other funds holding GMO

Vanguard Group's GMO Position: Q4 2020 in Review

Vanguard Group sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 2,352,989 shares — an estimated $263K sold.

Vanguard Group first reported a position in GMO in Q2 2013 and held it in 30 quarters. The position peaked at $4.12M in Q2 2013. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.

  • Vanguard Group reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
  • Vanguard Group sold 2,352,989 General Moly, Inc. shares in Q4 2020, an estimated $263K.
  • Vanguard Group first reported a position in General Moly, Inc. in Q2 2013 and held it in 30 quarters.
  • Vanguard Group's General Moly, Inc. position peaked at $4.12M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.

Based on Vanguard Group's 13F filing for Q4 2020, filed 12 Feb 2021.